XBiotech
XBIT
#6761
Rank
$0.24 B
Marketcap
$8.13
Share price
1.75%
Change (1 day)
144.14%
Change (1 year)

P/E ratio for XBiotech (XBIT)

P/E ratio as of March 2024 (TTM): -8.65

According to XBiotech's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -8.64894. At the end of 2022 the company had a P/E ratio of -3.25.

P/E ratio history for XBiotech from 2015 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-3.25-83.06%
2021-19.2-52.13%
2020-40.1-3787.75%
20191.09-112.41%
2018-8.76120.08%
2017-3.98-35.9%
2016-6.21-32.27%
2015-9.17

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-1.32-84.74%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-0.0045-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.35-84.38%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.